Metformin Hydrochloride; Repaglinide Patent Expiration
Metformin Hydrochloride; Repaglinide is used for managing blood glucose levels in patients with diabetes. It was first introduced by Novo Nordisk Inc
Metformin Hydrochloride; Repaglinide Patents
Given below is the list of patents protecting Metformin Hydrochloride; Repaglinide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prandimet | US6677358 | NIDDM regimen |
Jun 12, 2018
(Expired) | Novo Nordisk Inc |
Metformin Hydrochloride; Repaglinide's Family Patents
Explore Our Curated Drug Screens
Metformin Hydrochloride; Repaglinide Generic API Manufacturers
Several generic applications have been filed for Metformin Hydrochloride; Repaglinide.
Given below is the list of companies who have filed for Metformin Hydrochloride; Repaglinide generic, along with the locations of their manufacturing plants worldwide.
1. LUPIN LTD
Lupin Ltd has filed for 2 different strengths of generic version for Metformin Hydrochloride; Repaglinide. All of these versions come by the name REPAGLINIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG; 1MG | tablet | Discontinued | ORAL | N/A | Jul 15, 2015 |
| 500MG; 2MG | tablet | Discontinued | ORAL | N/A | Jul 15, 2015 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||